American International Group, Inc. Hookipa Pharma Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.31 $12,674 - $22,014	-9,530 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.26 - $2.52 $845 - $1,690	-671 Reduced 6.58%	9,530 $22,000
Q4 2021 Feb 11, 2022	SELL	$2.33 - $5.94 $710 - $1,811	-305 Reduced 2.9%	10,201 $24,000
Q3 2021 Nov 12, 2021	SELL	$5.89 - $9.35 $1,472 - $2,337	-250 Reduced 2.32%	10,506 $62,000
Q2 2021 Aug 13, 2021	BUY	$9.16 - $19.51 $21,773 - $46,375	2,377 Added 28.37%	10,756 $99,000
Q1 2021 May 07, 2021	BUY	$10.64 - $14.7 $12,278 - $16,963	1,154 Added 15.97%	8,379 $113,000
Q4 2020 Feb 12, 2021	SELL	$9.32 - $13.63 $1,929 - $2,821	-207 Reduced 2.79%	7,225 $80,000
Q3 2020 Nov 04, 2020	SELL	$8.59 - $11.89 $1,460 - $2,021	-170 Reduced 2.24%	7,432 $70,000
Q2 2020 Aug 12, 2020	BUY	$7.23 - $12.1 $12,305 - $20,594	1,702 Added 28.85%	7,602 $88,000
Q1 2020 May 04, 2020	SELL	$5.9 - $13.8 $2,006 - $4,692	-340 Reduced 5.45%	5,900 $49,000
Q4 2019 Feb 05, 2020	BUY	$6.51 - $12.23 $32,029 - $60,171	4,920 Added 372.73%	6,240 $76,000
Q3 2019 Nov 08, 2019	SELL	$6.45 - $8.44 $51 - $67	-8 Reduced 0.6%	1,320 $10,000
Q2 2019 Aug 13, 2019	BUY	$6.16 - $14.15 $8,180 - $18,791	1,328 New	1,328 $9,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $99.2M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.